Managing The Expansion of Clinical Trial Data Sources

Increases in remote patient monitoring and decentralized clinical trials – accelerated by COVID-19 – have added complexity to data management systems. Traditional platforms and electronic data capture used by drug development sponsors are ineffectual tools for integrating new primary data sources, or managing remote patient monitoring, Raj Indupuri, CEO at eClinical Solutions told In Vivo. 

Big data concept. 3D .Thousands bar graphs forming words big data
• Source: Shutterstock

Recently, many of the largest biopharmaceutical companies worldwide have gotten interested in modernizing their technology infrastructures and data management processes for clinical research, said Raj Indupuri, CEO at eClinical Solutions, a provider of cloud-based software for clinical data services. The practical realities of operating during COVID-19, as well as pressure from governments and patients, are prompting a reconsideration of technology needs. Remote patient monitoring has become critical to clinical research, as well as the need to integrate an ever-growing number of primary data sources into data management systems for analysis.

The problem with data management systems, said Indupuri, is that the increase in data sources “disrupts the traditional data review...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

More from In Vivo

Deals Shaping The Industry, May 2025

 
• By 

An interactive look at pharma, medtech and diagnostics deals made during May 2025. Data courtesy of Biomedtracker.

Podcast: Flagship’s Vision To Predict And Prevent Illness, With Raj Panjabi

 
• By 

Flagship Pioneering senior partner Raj Panjabi discusses shifting health care from reactive treatment to AI-powered prediction and prevention of disease before symptoms emerge.

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology

 

Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.